Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CR Bard stent cleared by FDA:

This article was originally published in Clinica

Executive Summary

CR Bard has received US FDA 510(k) clearance to market its Memotherm FLEXX, a biliary stent for treating malignant biliary obstructions. The device can negotiate sinuous anatomy and permit the stent to conform with curves in the biliary system, the company said. The Memotherm FLEXX also provides the radial strength to maintain patency.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT073075

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel